Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 415,200 | 269,000 | 181,700 | 168,000 | 139,400 |
| Receivables | 196,100 | 258,600 | 172,700 | 270,700 | 281,200 |
| Inventories | 270,100 | 236,200 | 248,100 | 222,500 | 230,200 |
| TOTAL | $958,800 | $795,900 | $626,600 | $686,200 | $700,000 |
| Non-Current Assets | |||||
| PPE Net | 606,500 | 580,100 | 549,200 | 542,300 | 529,100 |
| Intangibles | 944,600 | 959,500 | 974,500 | 979,500 | 996,300 |
| Other Non-Current Assets | 106,400 | 130,600 | 128,400 | 119,300 | 108,400 |
| TOTAL | $1,657,500 | $1,670,200 | $1,652,100 | $1,641,100 | $1,633,800 |
| Total Assets | $2,616,300 | $2,466,100 | $2,278,700 | $2,327,300 | $2,333,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 30,900 | N/A | 26,300 | 12,900 | 10,100 |
| Accounts payable and accrued liabilities | 102,800 | 84,800 | 84,200 | 94,800 | 91,300 |
| Accrued Expenses | 111,800 | 92,800 | 89,000 | 101,900 | 107,600 |
| Other current liabilities | 53,800 | 54,300 | 7,600 | 6,700 | 66,300 |
| TOTAL | $299,300 | $293,700 | $207,100 | $216,300 | $275,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 848,500 | 758,100 | 762,900 | 798,400 | 813,300 |
| Deferred Revenues | N/A | 29,100 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 153,000 | 151,600 | 170,000 | 74,600 | 149,100 |
| TOTAL | $1,065,500 | $973,600 | $996,800 | $1,022,500 | $1,023,500 |
| Total Liabilities | $1,364,800 | $1,267,300 | $1,203,900 | $1,238,800 | $1,298,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,999 | 52,925 | 52,428 | 52,000 | 51,624 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 541,500 | 502,000 | 409,300 | 421,800 | 374,900 |
| Other shareholders' equity | -21,000 | -21,800 | -20,800 | -9,500 | -8,800 |
| TOTAL | $1,251,500 | $1,198,800 | $1,074,800 | $1,088,500 | $1,035,000 |
| Total Liabilities And Equity | $2,616,300 | $2,466,100 | $2,278,700 | $2,327,300 | $2,333,800 |